Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Trends and Finance: Page 3
European Commission orders Illumina to sell Grail
Illumina has been ordered by the European Commission to sell Grail following the European Union antitrust regulatory body’s determination to prohibit the $8 billion acquisition of the company.
October 12, 2023
Tecan Genomics files patent infringement lawsuits against Qiagen, Invitae, others
Tecan Genomics has filed two separate lawsuits claiming patent infringement -- the first against Invitae, its subsidiary ArcherDx, and IDT (a subsidiary of Danaher); the second against Qiagen.
October 12, 2023
Fla. call center manager convicted in $67M fraudulent testing scheme
The manager of a Florida call center has been convicted by a federal jury in Ft. Pierce, FL, for his role in a $67 million fraudulent genetic testing scheme.
October 11, 2023
Bionano Genomics, Vizgen lay off employees
Bionano Genomics and Vizgen have executed layoffs this month.
October 11, 2023
Lab manager pleads guilty in $359M fraudulent testing scheme
A California woman has pleaded guilty to a $359 million fraudulent testing scheme.
October 10, 2023
Twist Bioscience, Bayer enter agreement on antibody discovery and licensing
Twist Bioscience and Bayer have signed an antibody discovery, option, and licensing agreement.
October 9, 2023
Oxford Nanopore collaboration makes classroom DNA sequencing accessible
An ambition to make in-classroom DNA sequencing routinely available, more user-friendly, and more egalitarian in U.S. universities and schools has been set out by a leading genetics educator.
October 9, 2023
Genomic Health to pay $32.5M to settle False Claims Act allegations
Genomic Health, a subsidiary of Exact Sciences, has agreed to pay $32.5 million to settle allegations by the U.S. Department of Justice that it violated the False Claims Act by engaging in a scheme to improperly bill Medicare for laboratory tests.
October 4, 2023
Abcam founder urges shareholders to reject $5.7B sale to Danaher
A founder of leading U.K. life sciences company Abcam has urged shareholders to reject a 4.5 billion pound ($5.7 billion) takeover bid by science and technology firm Danaher Corporation.
October 4, 2023
Investors acquire Novarum DX subsidiary from BBI Solutions
A group of investors have announced that they have finalized a deal to acquire diagnostics software company Novarum DX from U.K.-based BBI Solutions.
October 3, 2023
Harbinger Health raises $140M in series B funding
Biotech company Harbinger Health has raised $140 million in a series B funding round.
September 29, 2023
Day Zero Diagnostics to use $16M in funding to improve management of antibiotic-resistant infections
Day Zero Diagnostics recently raised $16 million to fund the application of whole-genome sequencing and artificial intelligence to antibiotic-resistant infections, facilitating the firm’s goal of changing how infectious diseases are diagnosed.
September 28, 2023
Previous Page
Page 3 of 126
Next Page
